You Searched For "biocon s kiran majumdar shaw" and got 15 results
Sort By:
Finance Minister Nirmala Sitharaman holds the first round of pre-budget talks with top industrialists
New Delhi, Dec.With the union budget-making process getting underway, Finance Minister Nirmala Sith…
India’s second richest woman nearly doubles her wealth to $4.6 billion during the COVID-19 pandemic
India’s super-rich club of 100 people has added nine new faces and about $88 billion collectively d…
Biocon Brings Dr Vijay Kuchroo And Dr Jeremy Levin On Board
Currently, Dr Kuchroo is the Samuel L Wasserstrom professor of Neurology at Harvard Medical School,…
Biocon’s Kiran Mazumdar Shaw, who debuted in the pharma industry with two employees and $500 becomes EY World Entrepreneur of the Year 2020
With this, she has joined the likes of Uday Kotak of Kotak Mahindra Bank and Narayana Murthy of …
True North to invest Rs 536.25 crore in Biocon Biologics for 2.44 pc stake
New Delhi, Jan 6 () Biotechnology major Biocon on Monday said private equity firm True North will i…
PTI
Kiran Mazumdar Shaw wanted to be a brewmaster before building the largest biotech company in India
Kiran Mazumdar Shaw is India’s richest self-made woman in India with a net worth of $3.2 billion. B…
Savitri Jindal, Kiran Mazumdar Shaw and Leena Tiwari — the only three women on Forbes list of 100 richest Indians
The list is topped by Reliance Industries’ chairman Mukesh Ambani for the 12th consecutive yea…
Kiran Mazumdar Shaw is No.2 on this global list. Know more
Mazumdar-Shaw has been ranked number two on The Medicine Maker Power List of 2015, which is an inde…
Meet India’s most generous women
Women have not only reached the pinnacle of success in their respective business ventures, they hav…
Commerce Ministry will have a more focused approach to revive exports
The Commerce Ministry today brought good news for reviving SEZs as it announced its plans to focus …
Government needs to make doing business easier with consistent policies, says Biocon chief Kiran Mazumdar-Shaw
"According to me, right now, the government needs to only focus on ease of doing business and it sh…
There are a lot of coronavirus vaccines in the works— but these are the two that Indians should watch out for
“I think the Oxford vaccine and Chinese vaccine are certainly in the more advanced clinical phas…
Kiran Mazumdar-Shaw to retire from Infosys board
Kiran Mazumdar-Shaw was appointed to the Infosys' Board as an Independent Director in 2014, and as …
ANI
Biocon Q4 net profit falls 42 pc to Rs 123 cr due to one-time COVID-19 impact
"On a full-year basis, we reported a revenue growth of 15 per cent led by a strong performance by …
PTI
Biocon gets DCGI nod for use of Itolizumab for treatment of COVID-19 patients
"As an innovation-led biopharmaceuticals company, I am proud of the successful outcome of the pivo…